Scynexis (SCYX) EBT Margin (2013 - 2025)
Scynexis (SCYX) reported EBT Margin of 65.74% for Q4 2025, up 51712.0% on a YoY basis from N/an in Q4 2024, and up 102.56% quarter-over-quarter from 2572.16% in Q3 2025.
Scynexis (SCYX) EBT Margin (2013 - 2025) Analysis & Trends
Scynexis has reported EBT Margin for 12 years, with the latest figure at 65.74% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin rose 51712.0% year-over-year to 65.74%; the trailing twelve-month figure through Mar 2026 stood at 96.45% (up 94773.0% YoY), and the FY2025 full-year result was 41.79%, up 52247.0% from the prior year.
- EBT Margin for Q4 2025 stood at 65.74%, up from 2572.16% in the prior quarter.
- The five-year high for EBT Margin was 93.01% in Q2 2023, with the low at 4906.03% in Q4 2021.
- Historically, EBT Margin has averaged 1139.43% across 5 years, with a median of 504.77% in 2025.
- Annual changes were most pronounced in 2022 — EBT Margin surged 395984 bps — and 2025, when it plunged 216627 bps.
- Scynexis' EBT Margin stood at 4906.03% in 2021, then surged by 81 bps to 946.19% in 2022, then surged by 65 bps to 335.48% in 2023, then tumbled by 35 bps to 451.38% in 2024, then soared by 115 bps to 65.74% in 2025.
- The last three EBT Margin figures came in at 65.74% (Q4 2025), 2572.16% (Q3 2025), and 504.77% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.74% |
| Sep 30, 2025 | -2,572.16% |
| Jun 30, 2025 | -504.77% |
| Mar 31, 2025 | -2,097.67% |
| Dec 31, 2024 | -451.38% |
| Sep 30, 2024 | -485.30% |
| Jun 30, 2024 | -1,964.40% |
| Mar 31, 2024 | 68.61% |
| Dec 31, 2023 | -335.48% |
| Sep 30, 2023 | -99.77% |
| Jun 30, 2023 | 93.01% |
| Mar 31, 2023 | -2,997.88% |
| Dec 31, 2022 | -946.19% |
| Sep 30, 2022 | -1,900.06% |
| Jun 30, 2022 | -1,008.69% |
| Mar 31, 2022 | -1,450.14% |
| Dec 31, 2021 | -4,906.03% |
| Sep 30, 2021 | -126.94% |
| Mar 31, 2021 | -29.68% |
| Jun 30, 2019 | -14,742.11% |